The UK pharmaceutical industry has struck a unique deal with the health service in Manchester that it says will transform patients' access to medicines.
In an effort to improvetheinternational response to combatting multidrug-resistant TB, MPP andJohns Hopkins University signlicensing agreement forinvestigational treatmentsutezolid